Closing remarks  by Dirks, John H.
Kidney International, Vol. 68 (2005), pp. 1451–1452
Closing remarks
JOHN H. DIRKS
Professor Emeritus of Medicine, University of Toronto, Toronto, Ontario, Canada; and Chair, International Society of Nephrology
(ISN), Commission for the Global Advancement of Nephrology (COMGAN)
I am deeply appreciative of being honored with a col-
loquium in my name. I thank my long-time friend Barry
Brenner for inviting these global authorities in cardio-
vascular and renal progression factors in chronic kidney
disease, and I thank Amgen, Inc., for making it possible.
I have been privileged to first co-chair COMGAN with
Barry Brenner, and then chair ISN COMGAN for the last
10 years. I believe that in that time it has left an impor-
tant stamp on the ISN as an international society. It is
firmly established that the ISN is truly global. The Soci-
ety’s mission of education has been both far-reaching and
satisfying.
In 2001, we proposed that the ISN should make the pre-
vention of chronic kidney disease its mission. I recall that
the discussion about this was brief and that the request
was quickly accepted. It was timely to have such a mission,
as the experimental data about the course of progres-
sive kidney disease and mitigating factors were being so
well developed by Dr. Brenner and others regarding hy-
perfiltration and elevated glomerular pressure, nephron
numbers, and proteinuria. This was followed by deci-
sive pharmacologic evidence that blockade to the renin-
angiotensin system, specifically, and control of systemic
blood pressure, in general, along with a reduction in uri-
nary albumin excretion slowed, stopped, and sometimes
reversed progression. Many corroborative clinical stud-
ies and clinical trials buttressed antiprogression strategies
again and again. We nephrologists became prevention
doctors and the nephrology literature exploded with new
information that our mentors never could have imagined
even a decade ago. We have created a virtual tsunami of
new knowledge about prevention.
Nephrologists then went global. We placed our new
knowledge in a worldwide context, realizing that the
global epidemic of diabetes is occurring in the developed
and, especially, in the developing worlds. World bodies
such as the World Health Organziation and the World
Bank started to identify noncommunicable diseases, or
chronic diseases, as the major health challenge of the 21st
century. Despite the continuing horrendous mortality of
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communicable diseases such as malaria, tuberculosis, hu-
man immunodeficiency virus, respiratory and diarrheal
disease, chronic diseases have surpassed them as the ma-
jor source of global mortality everywhere in the world
with the exception of sub-Saharan Africa.
COMGAN and ISN initiated programs for educa-
tion on prevention of chronic kidney disease through
early detection and sustained therapeutic intervention.
These have occurred in numerous countries with special
strategic meetings on every continent. Brilliantly led by
Research Committee Chair Giuseppe Remuzzi, a pro-
tocol for early screening and detection of chronic kid-
ney disease and its intervention has been developed. A
widespread interest has emerged in early referral and
workup of patients with microalbuminuria and reduced
glomerular filtration rate leading to implementation of
effective treatment and ongoing follow-up.
The symposium today reviewed the high risk of early
cardiovascular complications and mortality when chronic
kidney disease is identified. Conversely, the evolution of
cardiovascular disease, seen most demonstrably in the
dialysis patient, has been expounded. The risk factor list
is a growing one, involving deleterious aspects of anemia,
more understanding of direct or indirect sclerosing effects
of proteinuria, and calcium-phosphate elevations as risks
for vasculopathy
A longitudinal strategy of prevention of chronic kid-
ney disease has emerged, beginning with primary pre-
vention involving lifestyle changes leading to body weight
reduction, regular vigorous physical activity, and smoking
cessation. Secondary prevention using reduced glomeru-
lar filtration rate, and albuminuria as markers, and with
control of blood pressure, proteinuria, lipids, anemia and
calcium-phosphate has been identified. Finally, more in-
formed and more effective treatment of tertiary preven-
tion has been described once end-stage renal disease and
renal replacement therapy are at hand.
This has been a hallmark symposium and I could not
possibly have wished for anything more fulfilling. With-
out doubt, in the history of nephrology and certainly the
ISN, our most important achievement and priority is the
mission of prevention of chronic kidney disease and with
it cardiovascular disease and diabetes. I would challenge
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my successors to keep education and implementation of
prevention strategies very much on the front burner. I
am confident they will, and look forward to an ever-
expanding program of studies and practice that will truly
lower the global burden of chronic kidney disease.
I am deeply touched by this honor you have bestowed
on me today. Thank you.
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